FR2882931B1 - Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoidess et un agent antipsychotique - Google Patents
Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoidess et un agent antipsychotiqueInfo
- Publication number
- FR2882931B1 FR2882931B1 FR0502508A FR0502508A FR2882931B1 FR 2882931 B1 FR2882931 B1 FR 2882931B1 FR 0502508 A FR0502508 A FR 0502508A FR 0502508 A FR0502508 A FR 0502508A FR 2882931 B1 FR2882931 B1 FR 2882931B1
- Authority
- FR
- France
- Prior art keywords
- cannabinoidess
- receptors
- association
- pharmaceutical compositions
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0502508A FR2882931B1 (fr) | 2005-03-14 | 2005-03-14 | Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoidess et un agent antipsychotique |
PCT/FR2006/000532 WO2006097605A1 (fr) | 2005-03-14 | 2006-03-10 | Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoides et un agent antipsychotique |
MX2007011357A MX2007011357A (es) | 2005-03-14 | 2006-03-10 | Composiciones farmaceuticas que contienen en asociacion un compuesto antagonista de los receptores de cannabinoides y un agente antipsicotico. |
KR1020077023434A KR20070112266A (ko) | 2005-03-14 | 2006-03-10 | 칸나비노이드 수용체 길항제 화합물과 항정신병제의조합물을 함유하는 제약 조성물 |
AU2006224446A AU2006224446A1 (en) | 2005-03-14 | 2006-03-10 | Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent |
RU2007138042/15A RU2007138042A (ru) | 2005-03-14 | 2006-03-10 | Фармацевтические композиции, содержащие в сочетании соединение-антагонист рецепторов каннабиноидов и нейролептическое средство |
BRPI0608438-9A BRPI0608438A2 (pt) | 2005-03-14 | 2006-03-10 | composições farmacêuticas contendo em associação um composto antagonista dos receptores aos canabinóides e um agente antipsicótico |
JP2008501356A JP2008533110A (ja) | 2005-03-14 | 2006-03-10 | カンナビノイド受容体アンタゴニスト化合物および抗精神病薬剤の組合せを含有する医薬組成物 |
CA002600028A CA2600028A1 (fr) | 2005-03-14 | 2006-03-10 | Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoides et un agent antipsychotique |
EP06726063A EP1863489A1 (fr) | 2005-03-14 | 2006-03-10 | Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoides et un agent antipsychotique |
CNA2006800081089A CN101137373A (zh) | 2005-03-14 | 2006-03-10 | 含有大麻素受体拮抗化合物与防治精神病剂组合的药物组合物 |
IL185789A IL185789A0 (en) | 2005-03-14 | 2007-09-06 | Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent |
US11/854,032 US20080015186A1 (en) | 2005-03-14 | 2007-09-12 | Pharmaceutical compositions containing in combination a cannabinoid receptor antagonist and an antipsychotic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0502508A FR2882931B1 (fr) | 2005-03-14 | 2005-03-14 | Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoidess et un agent antipsychotique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2882931A1 FR2882931A1 (fr) | 2006-09-15 |
FR2882931B1 true FR2882931B1 (fr) | 2007-05-18 |
Family
ID=34955355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0502508A Expired - Fee Related FR2882931B1 (fr) | 2005-03-14 | 2005-03-14 | Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoidess et un agent antipsychotique |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080015186A1 (fr) |
EP (1) | EP1863489A1 (fr) |
JP (1) | JP2008533110A (fr) |
KR (1) | KR20070112266A (fr) |
CN (1) | CN101137373A (fr) |
AU (1) | AU2006224446A1 (fr) |
BR (1) | BRPI0608438A2 (fr) |
CA (1) | CA2600028A1 (fr) |
FR (1) | FR2882931B1 (fr) |
IL (1) | IL185789A0 (fr) |
MX (1) | MX2007011357A (fr) |
RU (1) | RU2007138042A (fr) |
WO (1) | WO2006097605A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20071092A1 (es) * | 2005-12-08 | 2007-12-10 | Aventis Pharma Inc | Composicion farmaceutica que comprende un antagonista de cb1 y un agente antisicotico |
ES2330071B1 (es) * | 2007-01-15 | 2010-07-05 | Laboratorios Del Dr. Esteve, S.A. | Combinacion de sustancias activas. |
EP1946777A1 (fr) * | 2007-01-16 | 2008-07-23 | Laboratorios del Dr. Esteve S.A. | Composés de pyrazoline substituée pour éviter la prise de poids |
GB2456183A (en) | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
US8566459B2 (en) | 2009-05-29 | 2013-10-22 | Red Hat, Inc. | Systems and methods for integrated console management interface |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
CA2537535A1 (fr) * | 2003-09-02 | 2005-03-10 | Solvay Pharmaceuticals Gmbh | Nouvelles utilisations medicales d'antagonistes selectifs du recepteur cb<sb>1</sb> |
-
2005
- 2005-03-14 FR FR0502508A patent/FR2882931B1/fr not_active Expired - Fee Related
-
2006
- 2006-03-10 CA CA002600028A patent/CA2600028A1/fr not_active Abandoned
- 2006-03-10 KR KR1020077023434A patent/KR20070112266A/ko not_active Application Discontinuation
- 2006-03-10 EP EP06726063A patent/EP1863489A1/fr not_active Withdrawn
- 2006-03-10 RU RU2007138042/15A patent/RU2007138042A/ru not_active Application Discontinuation
- 2006-03-10 WO PCT/FR2006/000532 patent/WO2006097605A1/fr active Application Filing
- 2006-03-10 BR BRPI0608438-9A patent/BRPI0608438A2/pt not_active IP Right Cessation
- 2006-03-10 MX MX2007011357A patent/MX2007011357A/es active IP Right Grant
- 2006-03-10 JP JP2008501356A patent/JP2008533110A/ja not_active Withdrawn
- 2006-03-10 AU AU2006224446A patent/AU2006224446A1/en not_active Abandoned
- 2006-03-10 CN CNA2006800081089A patent/CN101137373A/zh active Pending
-
2007
- 2007-09-06 IL IL185789A patent/IL185789A0/en unknown
- 2007-09-12 US US11/854,032 patent/US20080015186A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2882931A1 (fr) | 2006-09-15 |
CN101137373A (zh) | 2008-03-05 |
BRPI0608438A2 (pt) | 2009-12-29 |
EP1863489A1 (fr) | 2007-12-12 |
RU2007138042A (ru) | 2009-04-20 |
WO2006097605A1 (fr) | 2006-09-21 |
AU2006224446A1 (en) | 2006-09-21 |
MX2007011357A (es) | 2007-11-12 |
IL185789A0 (en) | 2008-02-09 |
US20080015186A1 (en) | 2008-01-17 |
KR20070112266A (ko) | 2007-11-22 |
JP2008533110A (ja) | 2008-08-21 |
CA2600028A1 (fr) | 2006-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2019010I1 (el) | Νεες ενωσεις και συνθεσεις και μεθοδοι χρησης | |
CY2017027I1 (el) | Σταθεροποιημενες συνθεσεις πτητικων αλκυλιωτικων παραγοντων και μεθοδοι χρησης αυτων | |
FR14C0020I1 (fr) | Compositions pharmaceutiques contenant du fentanyl pour application nasale | |
HUS1600025I1 (hu) | Egy angiotenzin receptor antagonistát és egy NEP inhibitort tartalmazó gyógyászati kombinációk | |
EP1765379A4 (fr) | Compositions pharmaceutiques de co-cristal et methodes d'utilisation associees | |
CY2015059I1 (el) | Συνθεσεις ξηρης σκονης γλυκοπυρρολικου και στεατικου μαγνησιου | |
SMT201400181B (it) | Composizioni per vasocostrizione e metodi d'uso | |
IL195161A0 (en) | Pharmaceutical compositions of ropinirole and methods of use thereof | |
EP2046736A4 (fr) | Composés arylsulfanylés et compositions pour administrer des agents actifs | |
ATE502634T1 (de) | N-methylaminomethyl-isoindol-verbindungen und diese enthaltende zusammensetzungen und diese verwendende verfahren | |
PL1861387T3 (pl) | Pochodne benzoimidazolu i ich kompozycje farmaceutyczne | |
EP2004175A4 (fr) | Composés augmentant l'activité anticancéreuse, formulations les contenant et leurs méthodes d'utilisation | |
IL197275A0 (en) | Pharmaceutical compositions of clonazepam and methods of use thereof | |
PL1888081T3 (pl) | Kompozycje zawierające PUFA i sposoby ich zastosowania | |
PL1824566T3 (pl) | Kompozycje doustne zawierające ekstrakt z rozmarynu i związane sposoby | |
BRPI0720124A2 (pt) | Composições farmacêuticas e seus métodos de uso. | |
EP1715853A4 (fr) | Compositions permettant d'administrer des agents hypnotiques dans la muqueuse orale et methodes d'utilisation | |
PL2027096T3 (pl) | Podstawione aryloimidazolony oraz triazolony jako inhibitory receptorów wazopresyny | |
PT1861387E (pt) | Derivados de benzimidazol e composições farmacêuticas dos mesmos | |
EP1713467A4 (fr) | Compositions et procedes d'utilisation de procyanidines de type a | |
FR2901273B1 (fr) | Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant | |
IL184158A0 (en) | Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use | |
FR2882931B1 (fr) | Compositions pharmaceutiques contenant en association un compose antagoniste des recepteurs aux cannabinoidess et un agent antipsychotique | |
BRPI0720684A2 (pt) | composto, medicamento, composição farmacêutica que contém e uso do composto | |
EP1968609A4 (fr) | Compositions pharmaceutiques et procedes pour l'utilisation de composes sulfhydryles hautement lipophiles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20111130 |